Rectal cancer Trials in Boston, United States
Conditions / Rectal cancer / Boston, United States
Research into Rectal cancer spans multiple therapeutic approaches and trial phases.
23 total trials for this combination
Showing top 10 of 23 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04674267 | Resilience and Equity in Aging, Cancer, and Health (REACH) | RECRUITING | NA |
| NCT04369053 | Prevention of Colorectal Cancer Through Multiomics Blood Testing | COMPLETED | — |
| NCT00911170 | PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study | COMPLETED | PHASE3 |
| NCT00819780 | PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors | COMPLETED | PHASE2 |
| NCT02810652 | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | COMPLETED | NA |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | COMPLETED | PHASE1/PHASE2 |
| NCT00973440 | Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal Malignancies | COMPLETED | — |
| NCT06239194 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT02632448 | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | COMPLETED | PHASE1/PHASE2 |